CRO giant Icon dialed up its fourth-quarter revenue on the way to a big year, forecasting another leap in 2015.
PRA Health Sciences, the latest CRO to go public, is expecting up to 10% revenue growth in 2015, hoping to top a transformational year that reshaped its business. Read more >>
After clearing roughly $4.2 billion in revenue in 2014, Quintiles is projecting another big year ahead, as the world's largest CRO counts on its backlog to keep business rolling in. Read more >>
POPULAR COMMENT THREADS
Months removed from a $150 million IPO, INC Research is looking to raise its profile among the world's largest CROs, inching toward the $1 billion annual revenue mark in the new year.
Catalent is investing in infrastructure again, spending to flesh out its European network of storage and packaging facilities in response to an increase in demand on the continent.
Enteris BioPharma is looking to make some money on the side of its drug-delivery operation, opening a contract manufacturing facility and scouting for clients.
One of the world's largest CROs is no longer an independent entity as Covance has folded into testing giant LabCorp, closing a $6 billion deal and altering the industry landscape.
Global CRO Quintiles is planning to lay off about 270 workers, 1% of its payroll, in an effort to reduce "excess capacity," the company said.
From Our Sister Sites
GE Ventures and Stanford Health Care (affiliated with Stanford University) just announced the launch of digital medicine company Evidation Health.
The FDA's lead spokesperson, Karen Riley, said she doesn't know why the agency didn't discover that Olympus' now discredited duodenoscope was being marketed without the agency's required clearance.